lab techSean Gallup/Getty Images

  • Gossamer Bio will go public Friday on the Nasdaq.
  • Shares priced at $16 apiece on Thursday evening, raising about $276 million.
  • Gossamer will trade under the ticker “GOSS.” 
READ  Christine Blasey Ford nonetheless unable to dwell at residence because of demise threats, attorneys say - US

Gossamer Bio priced its initial public offering on Thursday evening. 

The clinical-stage biopharmaceutical company that focuses on “discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology” priced its IPO at $16 a share, according to a press release out Thursday evening. The sale of 17.25 million shares will raise about $276 million. 

READ  GM cuts are a warning for all - US

BofA Merrill Lynch, SVB Leerink, Barclays and Evercore ISI were  joint book-running managers for the offering.

READ  'Capitalistic' America faces Canada struggle for hashish supremacy - US

Gossamer shares will trade on the Nasdaq, under the ticker “GOSS.” 


Please enter your comment!
Please enter your name here